瘤亡因子-α -308 G/A 慢性阻塞性肺病患者的遗传多态性,呈现出过度活跃的呼吸道
Pia Monique D Hipolito1, Peter F Quilala1, Mark Pierre S Dimamay2,3
1Department of Emergency Medicine, St. Luke's Medical Center, Quezon City 1112, Philippines.
Biomedical reports
|June 24, 2024
概括
瘤坏死因子-α (TNF-α) 基因变异可能会影响慢性阻塞性肺病 (COPD) 的发展. 这项研究没有发现TNF-α -308 G/A多态性和COPD或过度活跃的呼吸道之间的显著联系.
科学领域:
- 遗传学 遗传学 是一个
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题,往往是晚期诊断,延迟治疗.
- 瘤缩因子-α (TNF-α) 基因多态化与COPD的发病因子有关.
- 研究特定的TNF-α多态可能为COPD的发展和管理提供见解.
研究的目的:
- 确定TNF-α -308 G/A多态与COPD在患有过度活跃呼吸道的患者中的关联.
- 为了比较COPD患者中这种多形态的流行率,非COPD患者有过度活跃的呼吸道,和健康的对照.
- 评估多态性在呼吸道过活和COPD发展中的作用.
主要方法:
- 一个单一的中心,病例控制研究设计.
- 使用定量PCR进行了TNF-α -308 G/A多态的基因造型.
- 参与者包括有过度活跃的呼吸道的COPD患者,有过度活跃的呼吸道的非COPD患者和健康的对照.
主要成果:
- 在5% (G/A) 和1% (A/A) 的参与者中检测到TNF-α-308 G/A多态性.
- 最初的分析表明,COPD (29.3%) 和没有COPD (26.3%) 的高活性气道的几率降低,G/A多态.
- 多项逻辑回归没有显示出COPD或没有COPD的过活性呼吸道的几率有统计学意义的减少.
结论:
- 在TNF-α -308 G/A基因多态性显示没有显著的关联与COPD在患者,无论呼吸道过活.
- 观察到TNF-α -308 G/A多态化与患上COPD的可能性降低之间存在弱相关性.
- 需要进一步的研究来澄清TNF-α多态化在COPD病变发生过程中的确切作用.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Pathogenesis and Clinical Features
258
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
258
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195


